← Evidence map

ArticleNature chemical biology2026

De novo design of potent CRISPR-Cas13 inhibitors.

Cyntia Taveneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41588195